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INTRODUCTION:  Bladder  cancer  is  a signiﬁcant  epidemiological  disease.  It is  managed  by primary  resection
and  on-going  surveillance  for  recurrent  disease.  Intravesical  BCG  therapy  is used  in  superﬁcial  carcinomas
to  lower  the  incidence  of  recurrence  and  prolong  the time  to recurrence.  BCG  therapy  is not  without  its
rare  but  serious  side  effects.
PRESENTATION OF  CASE:  A 75-year-old  man  presented  to  the  urologist  with  right  testicular  pain,  after  four
previous  TURBT  operations,  two courses  of intravesical  BCG  therapy  and  one  STAT  dose  of  intravesical
mitomycin.  The  patient’s  USS  testis  showed  hypoechoic  lesions  in  the  right  testis.  An  orchiectomy  was
carried  out  due  to  the  possibility  of  the USS  showing  a  malignancy.  Histology  conﬁrmed  BCG  epididymo-
orchitis.
DISCUSSION:  This  patient  presented  with  testicular  pain  ﬁfteen  months  after  the cessation  of  BCG  ther-
apy.  Clinicians  need  to be  aware  of  the  potentially  long  dormancy  periods  for BCG  infections,  and  theirancer complications,  as  well  as  the  acute  infective  BCG  presentations.  The  literature  is  reviewed  and  shows  the
wide  range  of infective  BCG  presentations  from  acute  disseminated  sepsis  to  insidious  focal  infections
such  as parotiditis  and  discitis.
CONCLUSION: This  case  report  demonstrates  that due  to the  delayed  and  gradual  onset  of symptoms,  BCG
infections  are difﬁcult  to  diagnose.  The  report and  the  review  remind  surgeons  to keep  BCG  infection
amongst  their  differentials  when  treating  patients  who  present  after  BCG  therapy.
gical  © 2013 Sur
. Introduction
Bladder cancer remains a signiﬁcant epidemiological prob-
em with 11,000 new cases diagnosed every year.1 The use of
ntravesical Bacille Calmette–Guerin (BCG) as adjuvant therapy for
uperﬁcial G2T1 and G3 Ta/T1 bladder TCCs and as ablative treat-
ent for carcinomas in situ remains an important part of bladder
ancer management. Its use decreases the number of recurrences
nd delays the time to ﬁrst recurrence compared with trans-
rethral resection (TUR) alone.2
The complications of BCG therapy are well documented and it
s important that clinicians are aware of these. Commonly patients
xperience symptoms of cystitis and 28% of patients experience a
ow-grade fever with myalgia.3 Patients are given leaﬂets to warn
hem against nausea and vomiting, headaches, arthralgia, abdomi-
al pain and diarrhoea. Often these symptomsare due to a reactive
ypersensitivity response to BCG therapy. However patients are
old to seek medical advice with any persisting symptoms post
GC instillation. Severe side effects have been reported, high grade
ever seems to be the most common, occurring in 2.9% of patients.3
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A persistent fever for longer than 48 h or one that exceeds 38.5 ◦C
must be treated with isoniazid and BCG therapy must be stopped.4
Persistent fevers may  indicate disseminated mycobacterial infec-
tion, which requires aggressive anti-tuberculosis therapy.5 Many
post-BCG therapy infections have been described. These vary from
disseminated BCG infection with military pulmonary disease to
localised soft tissue infections like parotiditis6 and discitis.7 Here
we discuss a case of BCG epididymo-orchitis and carry out an exten-
sive literature review of infective BCG case reports.
2. Case report
In  March 2007 a 75-year-old man  was  referred for painless
haematuria. He had no previous urological history. The patient’s
medical history comprised of bilateral herniorrhaphies in 2000,
an MI  in 2004 and he suffers from ongoing osteoarthritis in the
metatarsophalangeal joints and in both elbow joints.
Flexible cystoscopy found a tumour near the right ureteric ori-
ﬁce. The patient’s tumour was resected and histology reported a
G2 pTa TCC bladder carcinoma. Post-op the patient was referred
for further check cystoscopies.
Open access under CC BY-NC-ND license.Check  cystoscopies at one year and eighteen months both
showed bladder cancer recurrence and the patient received two
additional TURBT operations. Due to his repeated recurrences the
patient had mitomycin after the ﬁrst TURBT and a six-week course
NC-ND license. 
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Fig. 1. USS right testis; longitudinal and transverse views. Multiple hypoechoic
areas  were demonstrated within the right testis. The head of the right epididymis
appears  enlarged and bulky. There is a hypoechoic lesion with solid areas measuring
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Table 1
Literature review showing the many reported complications of the BCG therapy.
Complication Frequency
Bladder BCG infection 5
Disseminated BCG infection 6
Epididymo-orchitis 11
Eye BCG infection 3
Granulomas of the penis 9
Granulomatous hepatitis 9
Infection of a hemiarthroplasty 1
Lymphangitis 2
Mono/polyarthitis 7
Muscle abscess 2
Mycobacterium tuberculomas in the brain 1
Mycotic Aneurysms 11
Osteomyelitis 4
Parotiditis 1
Prostatitis 8
Pulmonary granulomatous decease 12
Renal tuberculosis 8
Retroperitoneal abscess 2
Rieters syndrome 4
Spondylodiscitis 4.16 cm × 1.22 cm seen within the tail of the right epididymis. A small hydrocoele
as  demonstrated.
f intravesical BCG following the second. Again one year later check
ystoscopy revealed a red area on the posterior wall of the bladder,
hich after biopsy showed a G2pT1 carcinoma. TURBT followed
long with a second course of intravesical BCG. After the cessation
f the second bout of BCG therapythe patient suffered from multiple
pisodes of haematuria.
Fifteen  months later after the BCG therapy the patient pre-
ented complaining of right scrotal pain and swelling. The patient
ad multiple ultrasounds of his testes showing hypo-echoic areas
ithin the right testis and an enlarged bulky solid lesion within
he right epididymis (Fig. 1). The USS was ambiguous; blood tests
or testicular malignancy AFP, ßHCG and LDH were all normal. After
iscussion it was decided to perform a right-sided orchiectomy. The
ost op histology reported ‘numerous well-formed granulomas,
ome of which show central caseous necrosis, normal spermato-
enesis, no neoplasia or malignancy identiﬁed’. Special staining
ith Ziehl Neelsen stain reveals acid-fast bacilli positive organisms
n the necrotic areas. The diagnosis of BCG tubercular epididymo-
rchitis was conﬁrmed.
Post  right orchiectomy the patient was treated with quadru-
le anti-tuberculosis therapy (isoniazid, rifampicin, ethambutol
nd pyrazinamide) and referred to the respiratory physicians for
eview. The patient’s CXR was normal and the physicians were
appy to let the TB nurse specialists take over patient care. LFTs
ere checked regularly due the toxic effects of the anti-TB therapy
nd were not deranged.
The  patient continues to have regular ﬂexible cystoscopies
nd on two occasions has required rigid cystoscopy and biopsy
or red patches in the bladder. These have been described as
howing chronic inﬂammation with vascular congestion and
brosis. Surveillance ﬂexible cystoscopy and urine cytology will
ontinue.Systemic granulomatous reaction 7
Total 117
3. Discussion
We  conducted an extensive literature review of both the
pubmed and medline databases. We  used the keywords ‘intrav-
esical BCG therapy’ and ‘complications’. Only case reports were
included in our search results. We found 117 publications, Table 1
summarises our results. It shows the numerous ways a BCG infec-
tion can present.
Granulomatous prostatitis, epididymo-orchitis, renal abscess
and cystitis are considered as complications resulting from
BCG contaminated urine. Epididymo-orchitis is an infrequent
complication.3 This patient’s symptoms did not start until 15
months after his last course of BCG therapy. Case reports show that
epididymo-orchitis can occur up to 31 months after cessation of
BCG therapy.8 The fact that this patient had haematuria after the
second bout of BCG therapy may  mean the BCG invaded deeper into
the bladder wall thus increasing the probability of an infective side
effect.
In this case it was the urologist, who  ﬁrst suspected the patient
might have BCG epididymo-orchitis. The radiologist thought the
USS testes showed a malignancy.
The  orchidectomy was performed as a therapeutic and diag-
nostic procedure. The literature suggests that an orchidectomy is
only required if there is abscess formation within the testis, oth-
erwise anti-tuberculous therapy should be sufﬁcient.9 In this case
however, due to the difﬁculty of USS interpretation, an orchidec-
tomy was performed to treat a potential malignancy. In hindsight
after the positive Zeihl–Neelson staining and with the history of
BCG therapy 15 months earlier the USS appearance shows typical
granulomatous lesions and is diagnostic of BCG epididymo-orchitis
(Fig. 1).
4.  Conclusion
We  have reviewed the literature, which reports multiple cases
of BCG infections post BCG therapy. Here we  describe a case of
epididymo-orchitis, which presented ﬁfteen months post therapy.
Our literature review shows that post therapeutic BCG infections
can vary widely in their presentation. Acute reactive arthritis, acute
sepsis and multiorgan failure can occur as well as indolent infec-
tions like prostatitis and epididymo-orchitis. Clinicians should have
a high index of suspicion for BCG infection in any patient presenting
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